Moderna CEO on Covid Boosters, Flu Vaccine

The transcript covers Moderna's booster supply, the frequency of COVID-19 boosters, and the development of a combined flu and COVID booster. It discusses the safety of the Moderna vaccine for children aged 5-11 and addresses global vaccine distribution challenges, particularly in Africa. The conversation also highlights current vaccination rates and the need for improved infrastructure in low-income countries. Finally, it addresses myocarditis concerns related to the vaccine in teenagers and the status of vaccine approval in various regions.

What is the current vaccination gap among adults worldwide?

What challenges are faced in distributing vaccines to low-income countries?

What is the status of the vaccine approval for teenagers in the U.S. compared to other countries?